Document Detail


Endoscopic management of gastric variceal bleeding with cyanoacrylate glue injection: safety and efficacy in a Canadian population.
MedLine Citation:
PMID:  21037987     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND:  Gastric variceal bleeding (GVB) is a major cause of morbidity and mortality among patients with portal hypertension. Endoscopic band ligation and standard sclerotherapy have been used but have significant limitations. Decompression through transjugular intrahepatic portosystemic shunt insertion has been shown to be effective. Gastric variceal injection therapy with a commercially available cyanoacrylate glue is less invasive than transjugular intrahepatic portosystemic shunt insertion and has recently been shown to be effective for acute hemostasis. 
OBJECTIVE: To assess the immediate and long-term outcomes of cyanoacrylate glue injection therapy for GVB.
METHODS: A retrospective chart review was conducted to identify patients treated with cyanoacrylate injection for GVB at two tertiary care hospitals over a period of six years. The outcomes assessed included complications, acute hemostasis, rebleeding rate and all-cause mortality.
RESULTS: Thirty-seven patients (60% men) underwent cyanoacrylate glue injections for GVB. The median follow-up period was 14 months and included 29 patients (eight were lost to follow-up). Initial hemostasis was achieved in 35 patients (95%). No significant complications from cyanoacrylate injection were observed. Early rebleeding was rare (8%) and late rebleeding occurred in only 28% of patients. The all-cause mortality rate was 28.6% during the median follow-up period. 
CONCLUSION: The data suggest that cyanoacrylate injection therapy is safe and effective for the prevention of short- and long-term bleeding from gastric varices. Furthermore, although these patients had significant comorbid disease, survival in the follow-up time period was greater than 70%.
Authors:
Jaber Al-Ali; Monika Pawlowska; Alan Coss; Sigrid Svarta; Michael Byrne; Robert Enns
Related Documents :
2227317 - The role of endoscopic injection sclerotherapy in the management of bleeding peristomal...
14997127 - Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patient...
3055717 - Long-term injection sclerotherapy for the primary and secondary management of variceal ...
17653647 - Endoscopic hemostasis for bleeding gastric varices treated by combination of variceal l...
2857677 - Randomised double blind trial of somatostatin in the treatment of massive upper gastroi...
24788957 - Iodine mediated deprotection of n-tert-butanesulfinyl amines: a functional group compat...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Canadian journal of gastroenterology = Journal canadien de gastroenterologie     Volume:  24     ISSN:  0835-7900     ISO Abbreviation:  Can. J. Gastroenterol.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-11-01     Completed Date:  2011-02-17     Revised Date:  2014-01-17    
Medline Journal Info:
Nlm Unique ID:  8807867     Medline TA:  Can J Gastroenterol     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  593-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Canada
Cohort Studies
Enbucrilate / administration & dosage*
Endoscopy, Gastrointestinal*
Esophageal and Gastric Varices / complications,  pathology,  therapy*
Gastrointestinal Hemorrhage / etiology,  pathology,  therapy*
Hemostasis, Endoscopic*
Humans
Injections
Middle Aged
Retrospective Studies
Treatment Outcome
Chemical
Reg. No./Substance:
F8CEP82QNP/Enbucrilate
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant...
Next Document:  Efficacy and safety of a novel pegylated interferon alpha-2a in Egyptian patients with genotype 4 ch...